BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11728256)

  • 1. ACE inhibition and vascular remodeling of resistance vessels: vascular compliance and cardiovascular implications.
    Cohn JN
    Heart Dis; 2000; 2(2):S2-6. PubMed ID: 11728256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular wall function as a risk marker for cardiovascular disease.
    Cohn JN
    J Hypertens Suppl; 1999 Dec; 17(5):S41-4. PubMed ID: 10706325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
    Miller AL
    Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
    Neutel JM
    J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors.
    Galderisi M; de Divitiis O
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):523-31. PubMed ID: 18520954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL
    Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiotensin converting enzyme inhibitors and vascular remodelling in arterial hypertension].
    Garnier LF
    Ann Cardiol Angeiol (Paris); 1993 Oct; 42(8):438-44. PubMed ID: 8122853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On arterial physiology, pathophysiology of vascular compliance, and cardiovascular disease.
    Glasser SP
    Heart Dis; 2000; 2(5):375-9. PubMed ID: 11728285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
    Nichols WW
    Am J Hypertens; 2005 Jan; 18(1 Pt 2):3S-10S. PubMed ID: 15683725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of ACE inhibition on coronary endothelial dysfunction.
    Nickenig G; Stäblein A; Wassmann S; Wyen C; Müller C; Böhm M
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):361-4. PubMed ID: 11967824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme and vascular remodeling.
    Heeneman S; Sluimer JC; Daemen MJ
    Circ Res; 2007 Aug; 101(5):441-54. PubMed ID: 17761934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of vascular compliance in hypertension, aging and heart failure.
    Cohn JN; Finkelstein SM
    J Hypertens Suppl; 1992 Aug; 10(6):S61-4. PubMed ID: 1432329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ACE inhibition and atherosclerosis in the animal model].
    Becker RH
    Z Kardiol; 1994; 83 Suppl 4():15-20. PubMed ID: 7856276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular gap junctions and implications for hypertension.
    Rummery NM; Hill CE
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):659-67. PubMed ID: 15554905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits.
    Weckler N; Leitzbach D; Kalinowski L; Malinski T; Busch AE; Linz W
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):191-6. PubMed ID: 14608526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low sodium modifies the vascular effects of angiotensin-converting enzyme inhibitor therapy in healthy rats.
    Kocks MJ; Gschwend S; de Zeeuw D; Navis G; Buikema H
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1183-9. PubMed ID: 15175418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women.
    Teede HJ; McGrath BP; DeSilva L; Cehun M; Fassoulakis A; Nestel PJ
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1066-71. PubMed ID: 12714433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antihypertensive treatment on small artery remodeling in hypertension.
    Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):168-76. PubMed ID: 12710531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.